Yahoo Finance analysts compared the financial performance and 2026 outlook for healthcare companies AbbVie and Novo Nordisk. The analysis indicates that AbbVie reported revenues of $61.2 billion and net income of $4.2 billion in fiscal year 2025, with net income projected to surge to $14.6 billion and sales to increase to $67.2 billion in 2026. In contrast, Novo Nordisk recorded revenues of $48.2 billion and nearly $16.0 billion in net income in fiscal year 2025, but its sales are expected to decline by approximately 3% and net income to contract by 4% in 2026.